Search
Login
Register
Menu
Last issue
Home
News
CongressUpdate
Specials
Guidelines
Links
All
All
BJMO articles
Blog articles
Specials
Search
Forgot Password?
Not a member yet? Register here
Journal issues
>
Targeted Therapy Special, December 2024
Targeted Therapy Special, December 2024
Targeted Therapy Special, December 2024
Previous issue
Next issue
All issues
Subscribe
Quickly to
REVIEW ONCOLOGY
PRACTICE GUIDELINES
PHARMACOTHERAPY
RESEARCH
ONCOCASE
ONCOTHESIS
CONGRESS NEWS
REIMBURSEMENT NEWS
Index
SPECIAL
Managing CNS metastases in patients with EGFR-mutant non-small-cell lung cancer
T. Feys
Integrating PARPi and PSMA-targeted therapy in the management of patients with mCRPC
E. Dewulf
Trop-2 targeted therapy in breast cancer
E. Dewulf
Tumour-agnostic therapies in oncology: a big leap towards true treatment personalization
T. Feys
PHARMA NEWS
First-line osimertinib with or without chemotherapy across a broad range of patients with EGFR-mutated advanced NSCLC
Sacituzumab govitecan as a new treatment option for patients with pretreated, endocrine-resistant HR-positive HER2-negative metastatic breast cancer